GYRE — Gyre Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for Gyre Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	79.4	46.9	21.7	33.5	26.7
Net Total Accounts Receivable
Net Total Receivables	3.31	1.82	5	16.8	29.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	89.5	51.5	28.2	57.2	64.8
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.27	3.71	0.07	23.8	25.7
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	94.8	55.7	28.4	117	125
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	17.8	14.2	16.8	20	19.5
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	18.8	14.6	16.8	67.8	62.1
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	76.1	41.1	11.6	48.7	63.3
Total Liabilities & Shareholders' Equity	94.8	55.7	28.4	117	125
Total Common Shares Outstanding
Total Preferred Shares Outstanding